PACE-AF: Prospective Analysis of Cardiac Electrostimulation and Atrial Fibrillation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIlya Lukin
About this trial
PACE-AF is a prospective, observational patient registry designed to evaluate the impact of pacemaker algorithms on atrial fibrillation (AF) incidence, progression, and clinical outcomes in patients implanted with dual-chamber pacemakers. The registry aims to include 400-500 patients with longitudinal follow-up. Primary outcomes are progression to permanent AF and all-cause mortality. Secondary outcomes include quality of life, hospitalization, and cardiovascular events.
Eligibility criteria
Qualifiers
• Age ≥ 18 years
Implantation of a dual-chamber permanent pacemaker
Ability to provide informed consent
Willingness to participate in long-term follow-up
Disqualifiers
• Single-chamber pacemaker or Cardiac Resynchronization Therapy device at baseline
Life expectancy < 1 year due to non-cardiac comorbidities
Inability to comply with follow-up visits or device interrogation
Participation in another clinical trial that could interfere with study endpoints
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov